In the classification of HEATR7A inhibitors, the diversity of the compounds selected is deliberate to cover a broad range of signaling pathways. These compounds range from kinase inhibitors such as SB203580 and Wortmannin to more specialized inhibitors like Nutlin-3, which specifically interferes with MDM2-p53 interactions. The objective behind this array of chemicals is to intercept any functional associations that HEATR7A may have at multiple junctions. For instance, inhibitors like MG132 are designed to influence the ubiquitin-proteasome system, thereby directly impacting proteins involved in proteasomal degradation. On the other hand, PD98059 and ZM336372 function within the MEK/ERK and Ras/Raf/MEK/ERK pathways, respectively, targeting processes from cell differentiation to survival.
The strategy behind this lineup of chemical inhibitors is to allow for the simultaneous targeting of multiple functions or associations of HEATR7A. If HEATR7A is, for example, implicated in the PI3K/Akt pathway, both Wortmannin and LY294002 can serve to modulate its activity. Similarly, if HEATR7A is part of stress response mechanisms, the p38 MAPK inhibitor SB203580 would act on it. Moreover, given the unknowns concerning the precise biological function of HEATR7A, a broad-spectrum approach provides an empirical framework for elucidating the protein's role in various cellular contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can impair protein degradation. If HEATR7A has a role in proteasomal activities, MG132 will limit its function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that can modulate stress and inflammatory responses. If HEATR7A operates in these pathways, its activity will be inhibited. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that interferes with Akt signaling. If HEATR7A is involved in this pathway, Wortmannin will inhibit it. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that disrupts Akt signaling. If HEATR7A acts downstream or upstream of PI3K, LY294002 will inhibit it. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can disrupt cell differentiation processes. If HEATR7A is part of this pathway, SP600125 will inhibit it. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor that can influence cell survival. If HEATR7A is part of this pathway, its function will be impaired. | ||||||
ZM 336372 | 208260-29-1 | sc-202857 | 1 mg | $47.00 | 2 | |
c-Raf kinase inhibitor that can inhibit the Ras/Raf/MEK/ERK pathway. If HEATR7A is involved, this inhibitor will impair its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that acts on the MEK/ERK pathway. If HEATR7A is part of this signaling cascade, PD98059 will inhibit it. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
MDM2-p53 interaction inhibitor. If HEATR7A is involved in p53 regulation, Nutlin-3 can disrupt its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can affect protein synthesis and cell growth. If HEATR7A interacts with the mTOR pathway, Rapamycin will inhibit it. | ||||||